SyntheticMR’s software solution SyMRI will be featured in a presentation titled “Value of 3D Synthetic MRI in Clinical Imaging” at Canon Medical Systems’ sponsored Lunch Symposium. Dr. Shohei Fujita from the Department of Radiology at Juntendo University Hospital will present at the Annual Meeting of the Japanese Society for Magnetic Resonance in Medicine (JSMRM), which takes place September 10 to September 12. The presentation is being held on Friday, September 10, at 12:10.
 
The presentation follows the news that SyntheticMR entered a joint development project with Juntendo University Hospital and Canon Medical Systems, which was announced in June 2021. The project focuses on joint development and evaluation of quantitative MR imaging solutions for clinical practice.

For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com.

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 6-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for MSK anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked and FDA 510(k) pending. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit www.syntheticmr.com.